Featured Articles
-
Examining The Growth Of Biopharma In Developing Countries
3/26/2024
Support from local governments and renewed interest from biopharmaceutical companies are coalescing to drive growth in key developing markets.
-
Why Fusion Pharma Is The Latest Billion Dollar Big Pharma Buy In Radiopharmaceuticals
3/22/2024
AstraZeneca's $2.4 billion acquisition of Fusion Pharma is the third billion dollar radiopharmaceuticals deal in recent months. John Valliant, Fusion's founder and CEO, explains why alpha-emitters are better than beta-emitters, and why radiopharmaceuticals are poised for substantial growth.
-
What The Emerging Science Tells Us About Treating Obesity
3/20/2024
Treating obesity effectively is more complex than simply prescribing Wegovy or Zepbound. Awareness of new and established treatment options, and distinct phenotypes that contribute to obesity, will improve outcomes across heterogeneous patient groups.
-
Exploring Functional Uses Of AI In Life Sciences
3/19/2024
Generative AI is making an impact across functional areas at life sciences companies. This article provides current examples and use cases in drug discovery and clinical trials to manufacturing, commercialization, and patient monitoring.
-
Where Are They Now? Novo Nordisk
3/18/2024
In a few short years, Novo Nordisk has gone from belt-tightening to parachute pants, and is now replaying a GLP-1 competition with Eli Lilly that kicked off with Victoza and Trulicity ten years ago.
-
Five Lessons For Creating The Drug Development Leaders Of Tomorrow
3/15/2024
Inspiring and nurturing the drug development leaders of tomorrow throughout their school years, early work experiences, and their careers helps patients, companies, and society at large. AstraZeneca's Renee Iacona provides the how and why.
-
Doubling Down On Biopharma’s Growing Skills Drought
3/13/2024
The biopharmaceutical industry is building manufacturing capacity at breakneck speed. According to PhRMA, there are 1,580-and-counting biopharma manufacturing facilities in the U.S. alone. Problem is, we're way short on filling those facilities with skilled labor. NIIMBL wants to change that. Here's how, and a great opportunity for big pharma, biotech sponsors, CDMOs, academics, and more to help.
-
The Evolution Of Drug Packaging: Redefining Safety And Sustainability
3/13/2024
Drug packaging is undergoing a transformation, driven by regulatory pressures, consumer demand for eco-friendly solutions, labor issues, supply chain shortages, and the relentless pursuit of operational efficiency.
-
Reducing The Cost Of Cancer With Improved Diagnostics
3/12/2024
Better cancer diagnostics are needed to improve patient care and outcomes, and to reduce current healthcare costs associated with inefficient and convoluted diagnostic practices.
-
Debra Weiss, RN: Big Impact In Small, Non-Profit Bio
3/8/2024
The career of Debra Weiss, RN, MSN, and COO at the biopharma Gates Medical Research Institute (Gates MRI), offers a case study in creating success through service-oriented leadership.